Conventional medicine plays a crucial role in diagnosing, treating, and managing diseases through evidence-based interventions, including medications, surgeries, and other standardized treatments. However, there is a growing interest in integrative medicine, which combines conventional treatments with scientifically backed complementary therapies. This shift reflects a broader movement toward patient-centered, holistic healthcare that prioritizes both symptom relief…
Pharma has reached a crossroads, where the promise of science and innovation has met the reality of access issues, inefficiencies and shifting customer expectations.
So where do you go from here? Keep going down a path that’s clearly not working, or take a risk and innovate for the future?
You need to commit to a…
Join us for Reuters Events Digital Health 2025 on 12-13 May in Nashville, where we tackle the critical issues plaguing the healthcare sector today. As organizations face a stretched workforce and an outdated digital infrastructure, the urgency for transformation has never been greater. Current models of care are unsustainable, especially when addressing the diverse needs of an…
Where disruption meets direction
In the past year, pharma has witnessed disruption in the external environment and internal restructure. We’ve reorganized for patients and customers – but it’s one thing to change a job title, another to transform outcomes.
But how do you plan for the next wave of change across technology, regulations and expectations?
For over…
Shots:
The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences
In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding
Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…
Healthcare is evolving and requiring more from nurses. Today's nurse is an advocate, educator, and leader, no longer limited to clinical work. These new roles bring numerous opportunities for professional and personal growth. However, there needs to be more elbow room for the practice.
Ask yourself: Are you ready for your next giant leap in your…
Shots:
Driven by an endless pursuit of innovation, the biopharma industry is working tirelessly to bring new-age therapies to patients with serious health conditions and lifestyle-influenced diseases
In 2023, the global prescription drug market size was valued at $1162.61B and is anticipated to reach $2151.63B by 2032 registering a CAGR of 7.1 %. Keytruda ranks 1st…
External data reconciliation involves comparing and integrating data received from external data sources, such as labs, pharmacies, insurance providers, and other healthcare organizations, with internal systems. This process ensures patient information is consistent, complete, and reliable across all platforms.
The consequences of inaccurate or inconsistent external data can be significant, ranging from billing errors…
Shots:
With more than 50 percent of ongoing clinical trials, Oncology remains one of the most explored therapy areas in healthcare
In 2023, the global oncology market was valued at $222.36B and is envisioned to grow to $521.6B by 2033, registering a CAGR of 8.9% from 2024 to 2033. With $27.6B registered oncology revenue, Merck…
In the healthcare sector, user experience (UX) cannot be overestimated, because this directly affects both the effectiveness of the doctors themselves and the work of the hospital as a whole. UX design essentially guarantees the quality of interaction between the healthcare system and all its users, including patients, specialists, and healthcare providers. For example, a Healthcare…

